Sharad B. Murdande
Pfizer (United States)(US)
Publications by Year
Research Areas
Drug Solubulity and Delivery Systems, Crystallization and Solubility Studies, Analytical Chemistry and Chromatography, Analytical Methods in Pharmaceuticals, Metabolism, Diabetes, and Cancer
Most-Cited Works
- → Solubility advantage of amorphous pharmaceuticals: I. A thermodynamic analysis(2009)384 cited
- → Solubility Advantage of Amorphous Pharmaceuticals: II. Application of Quantitative Thermodynamic Relationships for Prediction of Solubility Enhancement in Structurally Diverse Insoluble Pharmaceuticals(2010)198 cited
- → Aqueous solubility of crystalline and amorphous drugs: Challenges in measurement(2010)152 cited
- → Discovery of (S)-6-(3-Cyclopentyl-2-(4-(trifluoromethyl)-1H-imidazol-1-yl)propanamido)nicotinic Acid as a Hepatoselective Glucokinase Activator Clinical Candidate for Treating Type 2 Diabetes Mellitus(2011)115 cited
- → Solubility Advantage of Amorphous Pharmaceuticals, Part 3: Is Maximum Solubility Advantage Experimentally Attainable and Sustainable?(2011)109 cited
- → Development of a self-emulsifying formulation that reduces the food effect for torcetrapib(2007)85 cited
- → Impact of Nanosizing on Solubility and Dissolution Rate of Poorly Soluble Pharmaceuticals(2015)83 cited
- → Sustained-release Morphine for Epidural Analgesia in Rats(1996)80 cited
- → A Review: Pharmaceutical and Pharmacokinetic Aspect of Nanocrystalline Suspensions(2015)71 cited
- → Discovery of small molecule isozyme non-specific inhibitors of mammalian acetyl-CoA carboxylase 1 and 2(2009)58 cited